TRPV4 and melanoma: Huang et al. (28) proved that overnight GSK101 exposure had no effect on HaCaT cell survival; however, Olivan-Viguera et al. (18) demonstrated that TRPV4 stimulated via GSK101 was able to inhibit the proliferation of melanoma cells and HaCaT keratinocytes.